2765676-02-4
Chemical Structure
CDK7-IN-15
- CAS No.: 2765676-02-4
- Formula:C21H24F4N6OS
- Molecular Weight:484.51
IUPAC Name: (S)-N-(3-(2-(piperidin-3-ylamino)-5-(trifluoromethyl)pyrimidin-4-yl)-1H-indol-7-yl)methanesulfonamide
InChIKey: VHKRETANALXMKM-RYUDHWBXSA-N
SMILES: CS(C)(=O)=NC1=C2NC=C(C2=CC=C1F)C3=NC(N[C@H]4CCC[C@@H](C4)N)=NC=C3C(F)(F)F
Biological Activity: CDK7-IN-15 (Compound 8) is a selective CDK7 inhibitor with an IC50 greater than 10 nM and less than or equal to 100 nM. CDK7-IN-15 is applicable to the research of cancers associated with transcriptional dysregulation[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CDK7-IN-15 | CDK7-IN-15 (Compound 8) is a selective CDK7 inhibitor with an IC50 greater than 10 nM and less than or equal to 100 nM. CDK7-IN-15 is applicable to the research of cancers associated with transcriptional dysregulation. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords